Expert opinion on "Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor drug in acute coronary syndrome"
.
Saved in:
Main Author: | S. Yu. Martsevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2023-09-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3686 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor in acute coronary syndrome
by: S. V. Lukyanov, et al.
Published: (2023-09-01) -
Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial
by: S. B. Fitilev, et al.
Published: (2022-03-01) -
Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01) -
Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group
by: S. B. Fitilev, et al.
Published: (2022-12-01) -
EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. I. Makhiyanova, et al.
Published: (2016-01-01)